Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 1906 AL 1920

Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease

Smit JW, Basile P, Prato MK, Detalle L, Mathy FX, Schmidt A, Lalla M, Germani M, Domange C, Biere AL, Bani M, Carson S, Genius J.

Mov Disord. 2022 Oct;37(10):2045-2056. doi: 10.1002/mds.29170. Epub 2022 Aug 12.

The Cognitive Profile of Atypical Parkinsonism: A Meta-Analysis

Raimo S, Gaita M, Cropano M, Mautone G, D'Iorio A, Trojano L, Santangelo G.

Neuropsychol Rev. 2023 Jun;33(2):514-543. doi: 10.1007/s11065-022-09551-6. Epub 2022 Aug 12.

Rhythmic serious games as an inclusive tool for music-based interventions

Dalla Bella S.

Ann N Y Acad Sci. 2022 Nov;1517(1):15-24. doi: 10.1111/nyas.14878. Epub 2022 Aug 17.

Case report: Combined therapy of bilateral subthalamic nucleus deep brain stimulation and spinal cord stimulation significantly improves motor function in a patient with multiple system atrophy with predominant parkinsonism

Li J, Mei S, Zhang X, Wang Y, Jia X, Liu J, Xu E, Mao W, Zhang Y.

Front Neurosci. 2022 Aug 1;16:929273. doi: 10.3389/fnins.2022.929273. eCollection 2022.

Measurement tools to assess activities of daily living in patients with Parkinson's disease: A systematic review

Bouça-Machado R, Fernandes A, Ranzato C, Beneby D, Nzwalo H, Ferreira JJ.

Front Neurosci. 2022 Jul 20;16:945398. doi: 10.3389/fnins.2022.945398. eCollection 2022.

The Role of Rab Proteins in Parkinson's Disease Synaptopathy

Bellucci A, Longhena F, Spillantini MG.

Biomedicines. 2022 Aug 10;10(8):1941. doi: 10.3390/biomedicines10081941.

Lipid Nanoparticles: Promising Treatment Approach for Parkinson's Disease

Jagaran K, Singh M.

Int J Mol Sci. 2022 Aug 19;23(16):9361. doi: 10.3390/ijms23169361.

Application of Neuromelanin MR Imaging in Parkinson Disease

He N, Chen Y, LeWitt PA, Yan F, Haacke EM.

J Magn Reson Imaging. 2023 Feb;57(2):337-352. doi: 10.1002/jmri.28414. Epub 2022 Aug 26.

Action observation and motor imagery have no effect on balance and freezing of gait in Parkinson's disease: a randomized controlled trial

Bezerra PT, Santiago LM, Silva IA, Souza AA, Pegado CL, Damascena CM, Ribeiro TS, Lindquist AR.

Eur J Phys Rehabil Med. 2022 Oct;58(5):715-722. doi: 10.23736/S1973-9087.22.07313-0. Epub 2022 Sep 1.

Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease

Ferreira JJ, Poewe W, Rascol O, Stocchi F, Antonini A, Moreira J, Guimarães B, Rocha JF, Soares-da-Silva P.

Mov Disord. 2022 Nov;37(11):2272-2283. doi: 10.1002/mds.29193. Epub 2022 Aug 31.

Use of Glycolysis-Enhancing Drugs and Risk of Parkinson's Disease

Simmering JE, Welsh MJ, Schultz J, Narayanan NS.

Mov Disord. 2022 Nov;37(11):2210-2216. doi: 10.1002/mds.29184. Epub 2022 Aug 22.

Uric Acid in Parkinson's Disease: What Is the Connection?

Seifar F, Dinasarapu AR, Jinnah HA.

Mov Disord. 2022 Nov;37(11):2173-2183. doi: 10.1002/mds.29209. Epub 2022 Sep 3.

Rasagiline as Adjunct to Levodopa for Treatment of Parkinson's Disease: A Systematic Review and Meta-Analysis

Kano O, Tsuda H, Hayashi A, Arai M.

Parkinsons Dis. 2022 Aug 30;2022:4216452. doi: 10.1155/2022/4216452. eCollection 2022.

Putaminal Recombinant Glucocerebrosidase Delivery with Magnetic Resonance-Guided Focused Ultrasound in Parkinson's Disease: A Phase I Study

Meng Y, Pople CB, Huang Y, Jones RM, Ottoy J, Goubran M, Oliveira LM, Davidson B, Lawrence LSP, Lau AZ, Bethune A, Maralani P, Abrahao A, Hamani C, Hynynen K, Kalia SK, Lipsman N, Kalia LV.

Mov Disord. 2022 Oct;37(10):2134-2139. doi: 10.1002/mds.29190. Epub 2022 Sep 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias